Dianthus Therapeutics | MGTA - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 952K 60K 2026-06
Avita Medical AUD 28.56M 534K 2026-06
Celltrion KRW 133.99B 14.77B 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Divis Laboratories Ltd INR 22.52B 3.01B 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 1.18B 223M 2026-09
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 100.45M 30.86M 2026-06
Organon & Co USD 1.19B 187M 2026-09
Ovoca Bio EUR 173K 990K 2025-12
Pharma Mar EUR 46.77M 4.24M 2026-09
Qiagen NV USD 393.64M 17.95M 2026-06
Revvity USD 604.27M 719K 2026-09
Sartorius EUR 746.5M 1.3M 2026-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 24.22M 3.08M 2026-06
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.49B 189.1M 2026-09
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.54B 90.74M 2026-09